Sign in
Taking peopleNo phase

Intermittent Theta Burst Stimulation of the Prefrontal Cortex in Social Anxiety Disorder

Key facts

Who runs it
Second Affiliated Hospital, Zhejiang University, School of Medicine
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
100 people, planned
Started
9 Dec 2025
Expected to end
1 Dec 2026
Type of study
Interventional, 3 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Active Intermittent Theta-Burst Stimulation (iTBS)
  • Sham Intermittent Theta-Burst Stimulation (iTBS)
Record updated
12 March 2026

Who can take part

Age
16 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 16 and 70 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to investigate the therapeutic effects of intermittent theta burst stimulation on social anxiety disorder and to track physiological changes in the brain using electroencephalography (EEG). Eligible SAD participants, after voluntarily signing an informed consent form, will first complete basic information collection, baseline questionnaire completion, and a pre-treatment EEG data collection session lasting approximately 30 minutes (including resting-state and task-state recordings). Subsequently, participants will be randomly assigned to one of three groups (left iTBS group, right iTBS group, or sham stimulation group) to receive intensive treatment for one week (4 sessions daily for 5 consecutive days, totaling 20 sessions). Immediately following the intervention, the research team will conduct post-treatment EEG data collection and gather questionnaire assessments. Participants will also undergo follow-up visits at weeks 2, 4, 6, and 8 post-treatment to complete questionnaires and report any adverse events. All study procedures are strictly and safely conducted by trained professionals. Participation is entirely voluntary, and participants may withdraw unconditionally at any time during the study.

The 3 groups in the trial

  • Left PFC-iTBSTreatment being tested

    Participants will receive active intermittent theta-burst stimulation (iTBS) targeting the left prefrontal cortex.

    Treatment: Active Intermittent Theta-Burst Stimulation (iTBS)

  • Right PFC-iTBSTreatment being tested

    Participants will receive active intermittent theta-burst stimulation (iTBS) targeting the right prefrontal cortex.

    Treatment: Active Intermittent Theta-Burst Stimulation (iTBS)

  • Sham iTBSSham treatment, for comparison

    Participants will receive sham intermittent theta-burst stimulation (iTBS) targeting the prefrontal cortex.

    Treatment: Sham Intermittent Theta-Burst Stimulation (iTBS)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Intermittent Theta-Burst Stimulation Targeting the Prefrontal Cortex for Social Anxiety Disorder: A Randomized, Parallel-Group Comparative Study
Criteria questions
Built from NCT07466277, who can take part
Record updated
12 March 2026